Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Die nächste Sicherheitsgeneration: Quantenresistente Technologie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
TH

WKN: A112C8 | ISIN: FR0010120402 | Ticker: 941
Stuttgart
17.11.26 | 15:33
0,580 Euro
+5,84 % +0,032
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERACLION SA Chart 1 Jahr
5-Tage-Chart
THERACLION SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,5530,62516:01

Aktuelle News zur THERACLION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.11.Theraclion Obtains FDA Authorization for Sonovein, Opening a New Era in Non-invasive Vein Care in the United States684Sonovein becomes the first non-invasive HIFU platform to receive U.S. marketing authorization for the treatment of superficial venous reflux in Great Saphenous Vein (GSV) segments through the...
► Artikel lesen
03.11.Theraclion Strengthens Its Growth Prospects in the Middle East by Obtaining Marketing Authorisation for Sonovein in Saudi Arabia394Regulatory News: THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for the non-invasive treatment of varicose veins using high-intensity...
► Artikel lesen
28.10.Theraclion Announces the Initiation of Coverage by TP ICAP Midcap With a Target Price of EUR 1.70, Confirming the Potential of Sonovein425Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused...
► Artikel lesen
16.09.2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development712Regulatory News: THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive treatment of varicose veins using High-Intensity...
► Artikel lesen
20.08.Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital531Article 223-16 du Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Listed on Euronext Growth Paris PEA PME eligible ISIN Code: FR0010120402 Website:...
► Artikel lesen
THERACLION Aktie jetzt für 0€ handeln
23.07.Theraclion Initiates Its Commercial Momentum in the First Half of 2026751Regulatory News: THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused...
► Artikel lesen
15.07.Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL521Regulatory News: Theraclion (Paris:ALTHE): Listing venue: Euronext Growth Paris PEA-PME eligible ISIN Code: FR0010120402 Website: www.theraclion.com Under the liquidity contract entrusted...
► Artikel lesen
09.07.Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors567Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused...
► Artikel lesen
02.07.Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital474Article 223-16 Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Listed on Euronext Growth Paris PEA PME eligible ISIN Code: FR0010120402 Website:...
► Artikel lesen
18.06.Theraclion Announces the Evolution of Its Board of Directors994Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused...
► Artikel lesen
08.06.Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code605Regulatory News: Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment...
► Artikel lesen
04.06.Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China658Regulatory News: THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the...
► Artikel lesen
03.06.Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital462Article 223-16 du Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Listed on Euronext Growth Paris PEA PME eligible ISIN Code: FR0010120402 Website:...
► Artikel lesen
01.06.Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented517Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse Theraclion...
► Artikel lesen
11.05.Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase574Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million Regulatory News: This press release and the information it contains...
► Artikel lesen
23.04.XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026791The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026 Aktien 1 ID1000132806 PT Multi Bintang Indonesia...
► Artikel lesen
20.04.Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription...959Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical...
► Artikel lesen
16.04.Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook802Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
29.01.Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up640Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
09.12.25Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements945Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1